Literature DB >> 9421486

Nitric oxide synthase (NOS) inhibition for one week improves renal sodium and water excretion in cirrhotic rats with ascites.

P Y Martin1, M Ohara, P Gines, D L Xu, J St John, M Niederberger, R W Schrier.   

Abstract

Normalization of the increased vascular nitric oxide (NO) generation with low doses of NG-nitro-L-arginine methyl ester (L-NAME) corrects the hemodynamic abnormalities of cirrhotic rats with ascites. We have undertaken this study to investigate the effect of the normalization of vascular NO production, as estimated by aortic cyclic guanosine monophosphate (cGMP) concentration and endothelial nitric oxide synthase (eNOS) protein expression in the aorta and mesenteric artery, on sodium and water excretion. Rats with carbon tetrachloride-induced cirrhosis and ascites were investigated using balance studies. The cirrhotic rats were separated into two groups, one receiving 0.5 mg/kg per day of L-NAME (CIR-NAME) during 7 d, whereas the other group (CIR) was administrated the same volume of vehicle. Two other groups of rats were used as controls, one group treated with L-NAME and another group receiving the same volume of vehicle. Sodium and water excretion was measured on days 0 and 7. On day 8, blood samples were collected for electrolyte and hormone measurements, and aorta and mesenteric arteries were harvested for cGMP determination and nitric oxide synthase (NOS) immunoblotting. Aortic cGMP and eNOS protein expression in the aorta and mesenteric artery were increased in CIR as compared with CIR-NAME. Both cirrhotic groups had a similar decrease in sodium excretion on day 0 (0.7 versus 0.6 mmol per day, NS) and a positive sodium balance (+0.9 versus +1.2 mmol per day, NS). On day 7, CIR-NAME rats had an increase in sodium excretion as compared with the CIR rats (sodium excretion: 2.4 versus 0.7 mmol per day, P < 0.001) and a negative sodium balance (-0.5 versus +0.8 mmol per day, P < 0.001). The excretion of a water load was also increased after L-NAME administration (from 28+/-5% to 65+/-7, P < 0.05). Plasma renin activity, aldosterone and arginine vasopressin were also significantly decreased in the CIR-NAME, as compared with the CIR rats. The results thus indicate that normalization of aortic cGMP and eNOS protein expression in vascular tissue is associated with increased sodium and water excretion in cirrhotic rats with ascites.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9421486      PMCID: PMC508560          DOI: 10.1172/JCI626

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  51 in total

1.  Arterial and cardiopulmonary baroreflex control of renal nerve activity in cirrhosis.

Authors:  M Rodríguez-Martínez; L L Sawin; G F DiBona
Journal:  Am J Physiol       Date:  1995-01

Review 2.  Influence of the renal medullary circulation on the control of sodium excretion.

Authors:  R J Roman; A P Zou
Journal:  Am J Physiol       Date:  1993-11

Review 3.  The nitric oxide hypothesis and the hyperdynamic circulation in cirrhosis.

Authors:  A Bomzon; L M Blendis
Journal:  Hepatology       Date:  1994-11       Impact factor: 17.425

4.  Renal effects of natriuretic peptide receptor blockade in cirrhotic rats with ascites.

Authors:  P Angeli; W Jiménez; V Arroyo; H S Mackenzie; P L Zhang; J Clària; F Rivera; B M Brenner; J Rodés
Journal:  Hepatology       Date:  1994-10       Impact factor: 17.425

5.  Therapeutic efficacy of the non-peptide AVP antagonist OPC-31260 in cirrhotic rats.

Authors:  Y Tsuboi; S Ishikawa; G Fujisawa; K Okada; T Saito
Journal:  Kidney Int       Date:  1994-07       Impact factor: 10.612

6.  Cirrhosis with ascites: increased atrial natriuretic peptide messenger RNA expression in rat ventricle.

Authors:  J E Poulos; W R Gower; H L Fontanet; G W Kalmus; D L Vesely
Journal:  Gastroenterology       Date:  1995-05       Impact factor: 22.682

7.  Nitric oxide production in arterial vessels of cirrhotic rats.

Authors:  J Ros; W Jiménez; S Lamas; J Clària; V Arroyo; F Rivera; J Rodés
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

8.  Reversal of atrial natriuretic peptide resistance by increasing distal tubular sodium delivery in patients with decompensated cirrhosis.

Authors:  W T Abraham; M E Lauwaars; J K Kim; R L Peña; R W Schrier
Journal:  Hepatology       Date:  1995-09       Impact factor: 17.425

9.  N omega-nitro-L-arginine administration corrects peripheral vasodilation and systemic capillary hypotension and ameliorates plasma volume expansion and sodium retention in portal hypertensive rats.

Authors:  F Y Lee; L A Colombato; A Albillos; R J Groszmann
Journal:  Hepatology       Date:  1993-01       Impact factor: 17.425

10.  Vascular hyporesponsiveness to endothelin 1 in rats with cirrhosis.

Authors:  M Hartleb; R Moreau; S Cailmail; C Gaudin; D Lebrec
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  13 in total

Review 1.  Water retention and aquaporins in heart failure, liver disease and pregnancy.

Authors:  R W Schrier; M A Cadnapaphornchai; M Ohara
Journal:  J R Soc Med       Date:  2001-06       Impact factor: 5.344

Review 2.  Acute kidney injury in patients with cirrhosis: perils and promise.

Authors:  Justin M Belcher; Chirag R Parikh; Guadalupe Garcia-Tsao
Journal:  Clin Gastroenterol Hepatol       Date:  2013-04-10       Impact factor: 11.382

3.  Effect of L-NAME on nitric oxide and gastrointestinal motility alterations in cirrhotic rats.

Authors:  Xin Wang; Yue-Xia Zhong; Zong-You Zhang; Ju Lu; Mei Lan; Ji-Yan Miao; Xue-Gang Guo; Yong-Quan Shi; Yan-Qiu Zhao; Jie Ding; Kai-Cun Wu; Bo-Rong Pan; Dai-Ming Fan
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

4.  Endothelin is an important determinant of renal function in a rat model of acute liver and renal failure.

Authors:  R Anand; D Harry; S Holt; P Milner; M Dashwood; D Goodier; M Jarmulowicz; K Moore
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

5.  The role of nitric oxide in the expression of renal aquaporin 2 in a cirrhotic rat model: does an AVP-independent mechanism exist for the regulation of AQP2 expression?

Authors:  Dae Won Jun; Jin Hee Park; Yoo Sin Park; Ju-Seop Kang; Eun Kyung Kim; Kyung Tae Kim; Byoung Kwan Son; Seong Hwan Kim; Yun Ju Jo; Young Sook Park
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

Review 6.  Asymmetric dimethylarginine as a mediator of vascular dysfunction in cirrhosis.

Authors:  Paloma Lluch; Gloria Segarra; Pascual Medina
Journal:  World J Gastroenterol       Date:  2015-08-28       Impact factor: 5.742

Review 7.  Molecular mechanism of edema formation in nephrotic syndrome: therapeutic implications.

Authors:  Alain Doucet; Guillaume Favre; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2007-06-07       Impact factor: 3.714

8.  The role of nitric oxide in portal hypertension caused by extrahepatic portal vein obstruction.

Authors:  P Goel; K Srivastava; N Das; V Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2010-10

9.  D-Galactosamine Intoxication in Experimental Animals: Is it Only an Experimental Model of Acute Liver Failure?

Authors:  Marek Saracyn; Robert Zdanowski; Marek Brytan; Grzegorz Kade; Zbigniew Nowak; Janusz Patera; Przemysław Dyrla; Jerzy Gil; Zofia Wańkowicz
Journal:  Med Sci Monit       Date:  2015-05-22

Review 10.  Hyponatremia in Patients with Cirrhosis of the Liver.

Authors:  Mauro Bernardi; Carmen Serena Ricci; Luca Santi
Journal:  J Clin Med       Date:  2014-12-31       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.